Results 21 to 30 of about 4,423,512 (307)

Vulvar Cancer: 2021 Revised FIGO Staging System and the Role of Imaging

Cancers, 2022
Simple Summary Primary vulvar malignancy is a rare gynecological neoplasm constituting 5–8% of cases. Considering the prognostic capability of staging, FIGO has introduced the revised 2021 staging for vulvar cancer. We review the etiopathogenesis revised
Mayur K. Virarkar, S. S. Vulasala, Taher Daoud, S. Javadi, C. Lall, P. Bhosale   +5 more
semanticscholar   +1 more source

Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis. [PDF]

PLoS ONE, 2018
The purpose of this study was to estimate the prevalence of human papillomavirus (HPV) in vulvar cancer and determine whether positive HPV in vulvar cancer was associated with a better prognosis. Literature searches of Ovid EMBASE, PubMed, Web of Science
Jianxin Zhang, Yang Zhang, Zhenyu Zhang
doaj   +1 more source

Secondary Vulvar Reconstruction Using Bilateral Gluteal Fold Flaps after Radical Vulvectomy with Direct Closure

Plastic and Reconstructive Surgery, Global Open, 2021
Summary:. Although primary vulvovaginal reconstruction after vulvectomy has high potential to improve patients’ outcomes, flap reconstruction is not an established part of the current standard treatment for vulvar cancer.
Solji Roh, MD, Shimpei Miyamoto, MD, Yutaro Kitamura, MD, Daisuke Mito, MD, Mutsumi Okazaki, MD   +4 more
doaj   +1 more source

Mechanisms of Resistance to Photodynamic Therapy (PDT) in Vulvar Cancer

International Journal of Molecular Sciences, 2022
Photodynamic therapy (PDT) is a valuable treatment method for vulvar intraepithelial neoplasia (VIN). It allows for the treatment of a multifocal disease with minimal tissue destruction.
B. Mossakowska, Somayeh Shahmoradi Ghahe, D. Cysewski, A. Fabisiewicz, B. Tudek, J. Siedlecki   +5 more
semanticscholar   +1 more source

Impact of a delayed diagnosis of vulvar cancer and its association with HIV infection: A 4-year review at a tertiary hospital in KwaZulu-Natal, South Africa

Southern African Journal of HIV Medicine, 2021
Background: Vulvar cancer is becoming more common in young women owing to the increased prevalence of co-infection with human papillomavirus and HIV. Objectives: The aim of this study was to determine the impact of the time interval from the diagnosis ...
Ramakhosana S. Hlapane, Thandekile L. Khumalo, Bongumusa S. Makhathini, Jagidesa Moodley   +3 more
doaj   +1 more source

Combined COX-2/PPARγ Expression as Independent Negative Prognosticator for Vulvar Cancer Patients

Diagnostics, 2021
Vulvar cancer incidence numbers have been rising steadily over the past decades. Especially the number of young patients with vulvar cancer increased recently.
Nadine Ansorge, Christian Dannecker, Udo Jeschke, Elisa Schmoeckel, Doris Mayr, Helene H. Heidegger, Aurelia Vattai, Maximiliane Burgmann, Bastian Czogalla, Sven Mahner, Sophie Fuerst   +10 more
doaj   +1 more source

The Role of Ultrasound in the Evaluation of Inguinal Lymph Nodes in Patients with Vulvar Cancer: A Systematic Review and Meta-Analysis

Cancers, 2022
Simple Summary Currently, around 30% of vulvar cancer cases at first diagnosis are spread to the inguinal lymph nodes. Preoperative staging of patients affected by vulvar carcinoma is still a hot topic.
D. Verri, F. Moro, S. Fragomeni, D. Zaçe, S. Bove, F. Pozzati, B. Gui, G. Scambia, A. Testa, G. Garganese   +9 more
semanticscholar   +1 more source

Radiotherapy Versus Inguinofemoral Lymphadenectomy as Treatment for Vulvar Cancer Patients With Micrometastases in the Sentinel Node: Results of GROINSS-V II

Journal of Clinical Oncology, 2021
PURPOSE The Groningen International Study on Sentinel nodes in Vulvar cancer (GROINSS-V)-II investigated whether inguinofemoral radiotherapy is a safe alternative to inguinofemoral lymphadenectomy (IFL) in vulvar cancer patients with a metastatic ...
Maaike H. M. Oonk, B. Slomovitz, P. Baldwin, H. V. van Doorn, J. van der Velden, J. D. de Hullu, K. Gaarenstroom, B. Slangen, I. Vergote, M. Brännström, E. van Dorst, W. V. van Driel, R. Hermans, D. Nunns, M. Widschwendter, D. Nugent, C. Holland, Aarti Sharma, P. DiSilvestro, R. Mannel, D. Boll, D. Cibula, A. Covens, D. Provencher, I. Runnebaum, D. Luesley, P. Ellis, T. Duncan, M. Tjiong, D. Cruickshank, P. Kjølhede, C. Levenback, J. Bouda, K. Kieser, C. Palle, N. Spirtos, D. O’Malley, M. Leitao, M. Geller, K. Dhar, V. Asher, K. Tamussino, D. Tobias, C. Borgfeldt, J. Lea, J. Bailey, M. Lood, B. Eyjólfsdóttir, S. Attard-Montalto, K. Tewari, R. Manchanda, P. T. Jensen, P. Persson, L. Van Le, H. Putter, G. D. de Bock, B. Monk, C. Creutzberg, A. van der Zee   +58 more
semanticscholar   +1 more source

Pembrolizumab in FIGO IVB Verrucous Carcinoma of the Vulva: A Case Report

Frontiers in Oncology, 2021
BackgroundVulvar cancer is the fourth most common gynecologic cancer, and prognosis is poor in advanced vulvar cancer patients. Treatment for advanced vulvar cancer has not been satisfactory.
Yuhan Wang, Rongchun Lin, Bingzhong Zhang, Hui Zhou, Zhongqiu Lin, Tingting Yao, Tingting Yao   +6 more
doaj   +1 more source

Lymphatic Function of the Lower Limb after Groin Dissection for Vulvar Cancer and Reconstruction with Lymphatic SCIP Flap

Cancers, 2022
Simple Summary Inguinal lymphadenectomy for vulvar cancer is often followed by secondary lower limb lymphedema. This significant treatment-related morbidity cannot be healed and worsens over time, causing symptoms significantly affecting the patients ...
A. Caretto, G. Stefanizzi, S. Fragomeni, A. Federico, L. Tagliaferri, V. Lancellotta, G. Scambia, S. Gentileschi   +7 more
semanticscholar   +1 more source